Comparing Erythromycin Ophthalmic vs Tobramycin Ophthalmic
| Erythromycin ophthalmic | Tobramycin ophthalmic |
|
|---|
| Erythromycin ophthalmic | Tobramycin ophthalmic |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Conjunctivitis - Bacterial. Erythromycin ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis - Bacterial. Tobramycin ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Conjunctivitis, Bacterial
Popular comparisons
|
|||||||||||||||
| More about Erythromycin ophthalmic | More about Tobramycin ophthalmic | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Erythromycin ophthalmic has an average rating of 5.6 out of 10 from a total of 16 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 25% reported a negative effect. |
Tobramycin ophthalmic has an average rating of 6.6 out of 10 from a total of 10 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 30% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Erythromycin ophthalmic side effects |
View all Tobramycin ophthalmic side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Erythromycin ophthalmic prices |
View all Tobramycin ophthalmic prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
AK-Tob, Tobrasol, Tobrex | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 9 drugs are known to interact with Tobramycin ophthalmic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
June 29, 1964 |
November 25, 1981 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.